Skip to content
Open Data Finder
Open Government Canada

Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL)

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or its salts" on the Prescription Drug List (PDL). Note that both the human and veterinary parts of the PDL were revised with the addition of a qualifier.

Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) · Open Data Finder